AETHER
Aether Industries Limited
Specialty chemicals and contract research and manufacturing services provider
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
aether.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Aether (Aether Industries) makes specialty chemicals and supplies contract research and manufacturing services (CRAMS) and contract or exclusive manufacturing (CEM) to domestic and global customers.
Company snapshot
5thBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓Net margin of 19.8% — the business keeps a healthy share of every rupee it earns.
- ✗Over the last three years operations used more cash than they brought in, despite an operating profit — the business is not yet turning its profit into cash.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 164 Cr | 155 Cr | 118 Cr | 180 Cr | 199 Cr | 220 Cr | 240 Cr | 256 Cr | 275 Cr | 317 Cr | 305 Cr | 327 Cr |
| Operating expenses (approx.) | 118 Cr | 124 Cr | 107 Cr | 137 Cr | 145 Cr | 155 Cr | 161 Cr | 175 Cr | 187 Cr | 207 Cr | 222 Cr | 224 Cr |
| EBITDA | 46 Cr | 31 Cr | 10 Cr | 43 Cr | 54 Cr | 65 Cr | 80 Cr | 81 Cr | 88 Cr | 111 Cr | 83 Cr | 103 Cr |
| OPM % | 28.0% | 20.2% | 8.7% | 24.0% | 27.0% | 29.5% | 33.2% | 31.5% | 32.0% | 34.9% | 27.1% | 31.5% |
| Other income | 14 Cr | 11 Cr | 12 Cr | 12 Cr | 11 Cr | 14 Cr | 5 Cr | 3 Cr | 9 Cr | 0.11 Cr | 11 Cr | 8 Cr |
| Interest | 2 Cr | 2 Cr | 4 Cr | 3 Cr | 2 Cr | 3 Cr | 5 Cr | 5 Cr | 3 Cr | 4 Cr | 6 Cr | 6 Cr |
| Depreciation | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 11 Cr | 11 Cr | 13 Cr | 14 Cr | 17 Cr | 17 Cr | 18 Cr | 21 Cr |
| Profit before tax | 49 Cr | 24 Cr | 0.38 Cr | 39 Cr | 49 Cr | 61 Cr | 64 Cr | 62 Cr | 74 Cr | 87 Cr | 68 Cr | 83 Cr |
| Tax % | 24.7% | 26.8% | 476.8% | 23.9% | 28.3% | 29.3% | 21.1% | 23.7% | 27.3% | 26.0% | 20.6% | 24.8% |
| Net profit | 37 Cr | 17 Cr | -1 Cr | 30 Cr | 35 Cr | 43 Cr | 50 Cr | 47 Cr | 54 Cr | 64 Cr | 54 Cr | 63 Cr |
| EPS (₹) | ₹2.77 | ₹1.32 | ₹-0.11 | ₹2.26 | ₹2.63 | ₹3.27 | ₹3.79 | ₹3.55 | ₹4.07 | ₹4.86 | ₹4.07 | ₹4.77 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 651 Cr | 598 Cr | 839 Cr | 1,160 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 465 Cr | 466 Cr | 598 Cr | 797 Cr | Sign in free for the trailing twelve months |
| EBITDA | 186 Cr | 132 Cr | 241 Cr | 364 Cr | Sign in free for the trailing twelve months |
| OPM % | 28.6% | 22.1% | 28.8% | 31.3% | Sign in free for the trailing twelve months |
| Other income | 17 Cr | 39 Cr | 42 Cr | 21 Cr | Sign in free for the trailing twelve months |
| Interest | 5 Cr | 9 Cr | 13 Cr | 18 Cr | Sign in free for the trailing twelve months |
| Depreciation | 23 Cr | 40 Cr | 45 Cr | 66 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 174 Cr | 110 Cr | 213 Cr | 291 Cr | Sign in free for the trailing twelve months |
| Tax % | 25.3% | 24.7% | 25.6% | 21.1% | Sign in free for the trailing twelve months |
| Net profit | 130 Cr | 82 Cr | 158 Cr | 230 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹10.47 | ₹6.22 | ₹11.95 | ₹16.55 | Sign in free for the trailing twelve months |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | 125 Cr | 133 Cr | 133 Cr | 133 Cr |
| Reserves | 1,120 Cr | 1,931 Cr | 2,093 Cr | 2,323 Cr |
| Borrowings | 0.11 Cr | 169 Cr | 197 Cr | 442 Cr |
| Other liabilities | 135 Cr | 169 Cr | 221 Cr | 304 Cr |
| Total liabilities | 1,380 Cr | 2,401 Cr | 2,644 Cr | 3,201 Cr |
| Fixed assets (net) | 533 Cr | 693 Cr | 944 Cr | 1,236 Cr |
| CWIP | 37 Cr | 226 Cr | 355 Cr | 506 Cr |
| Investments | 1 Cr | 0.21 Cr | 0.21 Cr | 0.21 Cr |
| Loans & advances | 1 Cr | 1 Cr | 2 Cr | 1 Cr |
| Inventories | 249 Cr | 343 Cr | 397 Cr | 537 Cr |
| Trade receivables | 259 Cr | 233 Cr | 289 Cr | 390 Cr |
| Cash & bank | 71 Cr | 5 Cr | 17 Cr | 6 Cr |
| Other assets | 229 Cr | 898 Cr | 640 Cr | 525 Cr |
| Total assets | 1,380 Cr | 2,401 Cr | 2,644 Cr | 3,201 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from operating activity | -7 Cr | -16 Cr | 135 Cr | -145 Cr |
| Cash from investing | -348 Cr | -424 Cr | -452 Cr | -327 Cr |
| Cash from financing | 439 Cr | 894 Cr | 2 Cr | 239 Cr |
| Net cash flow | 84 Cr | 453 Cr | -316 Cr | -233 Cr |
| Free cash flow (OCF − Capex) | -408 Cr | -265 Cr | -170 Cr | -237 Cr |
Ratios
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROCE % | 14.4% | 5.3% | 9.3% | 10.7% |
| ROE % | 10.5% | 4.0% | 7.1% | 8.9% |
| Debtor days | 145 | 142 | 125 | 122 |
| Inventory days | 239 | 332 | 285 | 287 |
| Days payable | 78 | 100 | 92 | 105 |
| Cash conversion cycle | 305 | 374 | 319 | 304 |
| OCF / EBITDA % | -3.5% | -12.4% | 55.8% | -40.0% |
| OCF / EBITDA % (3 years) | — | — | 19.9% | -3.7% |
| Debt / equity | 0.0001 | 0.08 | 0.09 | 0.18 |
| Current ratio | 7.18 | 4.51 | 3.25 | 1.78 |
| Net debt / EBITDA | -0.38 | 1.23 | 0.75 | 1.20 |